Anaconda Medical

Developing next-generation thrombectomy systems for the treatment of ischemic stroke.

Medical Devices
Active
Barcelona, Israel Founded 2025
Website ↗
Last updated 2026-08-06
Total raised
Stage
Founded
2025
Headcount
HQ
Barcelona, Israel
Sector
Medical Devices

About

Anaconda Biomed S.L. is a medical technology company dedicated to developing next-generation thrombectomy systems for the treatment of ischemic stroke. Their flagship product, the ANA5 Advanced Neurovascular Access™ Thrombectomy Device, is designed to improve clot capture and removal during neurovascular procedures.

Funding history · 3 rounds · — total

2019-12
B Round $20.0M
★ Asabys PartnersSabadell Asabys Health Innovation Investments SCR, SAYsios CapitalOmega FundsInnogestSabadell Venture Capital
2019-12
Debt Financing $10.0M
★ European Investment Bank
2017-05
A Round $16.2M
★ Ysios Capital★ Omega Funds★ Banco SabadellInnogest Capitalother investors

Team · 9

Ofir Arad
Founder · Co-Founder and Managing Director
Marc Ribó
Founder · Co-Founder
Trent Reutiman
CEO
Hendrik Lambert
CMO
Iñaki Galve
R&D Director
Maria Jose Alonso
Finance Director
Jordi Cardona
Operations Director
Chuck Carignan
Board Chairman
Thomas Harth
Board Member (YSIOS CAPITAL)

Sectors & technology

Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteanacondabiomed.com/

Identifiers & details

Legal nameAnaconda Medical
Founded2025

Radar intelligence

Patents

EPO1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)517091088
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2025-01-05
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Active charges / liens0
Registry events3 — shares_capital (1), name_change (1), people (1)
Name changes2026-01-25
Registered addressואדי אל-חאג' 13 נצרת

Recent registry events

DateEvent
2026-01-27הקצאת מניות
2026-01-25שינוי שם
2026-01-22עדכון בעלי תפקידים